Temasek subscribes to capital increase and acquires approximately 3.6 percent of Bayer

Investment by renowned long-term investor affirms Bayer’s strategy ...

CVBD® World Forum predict future vector-borne disease threats

The 13th CVBD® (Companion Vector-Borne Diseases) World Forum saw parasitologists, veterinary clinicians and epidemiology experts from around the world discuss vector-borne disease threats ...

Bayer to showcase data from diverse oncology pipeline at AACR 2018

Research to be presented on Bayer’s key areas of investigation, including Oncogenic Signaling, Targeted Thorium Conjugates and Immuno-Oncology ...

Bayer hones its brand profile

Bayer and The Nature Conservancy Brazil are joining forces for more sustainable agriculture in Brazil

Partnership started in March / Support for farmers in Mato Grosso state to comply with Brazil’s environmental legislation by offering technical assistance ...

New winners of Bayer Early Excellence in Science Award: EUR 30,000 for international research scientists

Dr. Christoph Engel (University of Regensburg (Germany) wins the “Biology“ category / Dr. Keary M. Engle (Scripps Research Institute La Jolla, CA, USA) takes the “Chemistry“ award ...

Bayer announces completion of rolling submission of New Drug Application in the U.S. for larotrectinib for the treatment of TRK fusion cancer

Bayer, Exeter University and Rothamsted Research to identify enzymes in bees that determine sensitivity to neonicotinoids

Comprehensive study recently published in Current Biology / Research findings will improve Bayer’s ability to develop new selective insecticides ...

European Commission conditionally approves Bayer’s proposed acquisition of Monsanto

Closing of transaction planned for the second quarter of 2018 ...

Bayer partners World Farmers’ Organisation to launch global Care4Cattle grant to advance cattle well-being

Global Care4Cattle initiative offers EUR 30,000 in support of innovative thinking towards enhancing cattle well-being on farm level ...